SavedAdd your journal

Journals / The European Research Journal / 2026 / Volume: 12 Issue: 2

Therapeutic Effects of Alpha-Lipoic Acid on High-Dose Ibuprofen-Induced Renal Damage in Rats

Halime Tozak Yıldız(Department of Histology and Embryology, Faculty of Medicine, Kırşehir Ahi Evran University, Kırşehir, Türkiye)0000-0003-4310-6238
Pages
—
Publication Date
2026-02-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: Alpha-lipoic acid exerts renoprotective effects against ibuprofen-induced nephrotoxicity by reducing oxidative stress, modulating fibrotic pathways, and improving renal histoarchitecture, suggesting its potential as a therapeutic agent in drug-induced kidney injury.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Nonsteroidal anti-inflammatory drugs, particularly ibuprofen, are commonly used worldwide and can cause nephrotoxicity through prostaglandin inhibition, oxidative stress, and inflammatory activation.
📊
Key Findings & Data:Methods: Twenty-eight male Wistar albino rats were randomly divided into four groups (n=7): Control, Alpha-lipoic acid (100 mg/kg), Ibuprofen (250 mg/kg), and Ibuprofen+Alpha-lipoic acid.
💡
Conclusion & Impact:Conclusions: Alpha-lipoic acid exerts renoprotective effects against ibuprofen-induced nephrotoxicity by reducing oxidative stress, modulating fibrotic pathways, and improving renal histoarchitecture, suggesting its potential as a therapeutic agent in drug-induced kidney injury.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ibuprofen · Alpha-Lipoic Acid · Nephrotoxicity

Abstract

Objectives: Nonsteroidal anti-inflammatory drugs, particularly ibuprofen, are commonly used worldwide and can cause nephrotoxicity through prostaglandin inhibition, oxidative stress, and inflammatory activation. This study aimed to investigate the histopathological, fibrotic, and oxidative effects of high-dose ibuprofen administration and to evaluate the therapeutic potential of alpha-lipoic acid) in reversing these changes. Methods: Twenty-eight male Wistar albino rats were randomly divided into four groups (n=7): Control, Alpha-lipoic acid (100 mg/kg), Ibuprofen (250 mg/kg), and Ibuprofen+Alpha-lipoic acid. Ibuprofen was administered orally for 21 days, while alpha-lipoic acid was given during the last 7 days. Histopathological changes were evaluated using Hematoxylin & Eosin, Masson’s Trichrome, and Periodic Acid–Schiff staining. Fibrotic and inflammatory markers (TGF-β1, α-SMA, TLR-4) were assessed immunohistochemically. Oxidative stress was evaluated by measuring malondialdehyde levels and superoxide dismutase activity. Results: Ibuprofen administration resulted in significant tubular degeneration, hydropic changes, necrosis, tubular dilatation, and hyperemia. Masson’s Trichrome staining showed a significant increase in collagen deposition, while Periodic Acid-Schiff staining revealed glomerular and tubular basement membrane thickening. Immunohistochemistry demonstrated marked upregulation of TGF-β1, α-SMA, and TLR-4 (P<0.001). Biochemically, malondialdehyde levels were significantly increased (P<0.01) and superoxide dismutase activity was markedly decreased (P<0.001) compared to controls. Alpha-lipoic acid treatment significantly ameliorated these changes, reducing fibrosis and inflammatory marker expression and restoring malondialdehyde and superoxide dismutase levels toward normal (P<0.05). Conclusions: Alpha-lipoic acid exerts renoprotective effects against ibuprofen-induced nephrotoxicity by reducing oxidative stress, modulating fibrotic pathways, and improving renal histoarchitecture, suggesting its potential as a therapeutic agent in drug-induced kidney injury.

🔖

Cite This Article

Yıldız, H. T. (2026). Therapeutic Effects of Alpha-Lipoic Acid on High-Dose Ibuprofen-Induced Renal Damage in Rats. The European Research Journal, Volume: 12 Issue: 2. https://doi.org/10.18621/eurj.1785523

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (30)

  1. Tai FWD, McAlindon ME. Non-steroidal anti-inflammatory drugs and the gastrointestinal tract. Clin Med (Lond). 2021;21(2):131-134. doi: 10.7861/clinmed.2021-0039.
  2. Ngo VTH, Bajaj T. Ibuprofen. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025 Jan-. Updated August 11, 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK542299/
  3. Dobrek L. A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life (Basel). 2023;13(2):325. doi: 10.3390/life13020325.
  4. Bindu S, Mazumder S, Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020;180:114147. doi: 10.1016/j.bcp.2020.114147.
  5. Kaufman DP, Basit H, Knohl SJ. Physiology, glomerular filtration rate. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025 Jan-. Updated July 17, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK500032/
  6. Sriuttha P, Sirichanchuen B, Permsuwan U. Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials. Int J Hepatol. 2018;2018:5253623. doi: 10.1155/2018/5253623.
  7. Ghlichloo I, Gerriets V. Nonsteroidal anti-inflammatory drugs (NSAIDs). In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2025 Jan-. Updated May 1, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK547742/
  8. Hörl WH. Nonsteroidal Anti-Inflammatory Drugs and the Kidney. Pharmaceuticals (Basel). 2010;3(7):2291-2321. doi: 10.3390/ph3072291.
  9. Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY. Diverse Role of TGF-β in Kidney Disease. Front Cell Dev Biol. 2020;8:123. doi: 10.3389/fcell.2020.00123.
  10. Tang PC, Chan AS, Zhang CB, et al. TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases. Front Med (Lausanne). 2021;8:628519. doi: 10.3389/fmed.2021.628519.
  11. Brandolini L, Antonosante A, Giorgio C, et al. NSAIDs-dependent adaption of the mitochondria-proteasome system in immortalized human cardiomyocytes. Sci Rep. 2020;10(1):18337. doi: 10.1038/s41598-020-75394-x.
  12. Superti F, Russo R. Alpha-Lipoic Acid: Biological Mechanisms and Health Benefits. Antioxidants (Basel). 2024;13(10):1228. doi: 10.3390/antiox13101228.
  13. Wang Y, Jiang S, He Y, Pang P, Shan H. Advances in α-Lipoic Acid for Disease Prevention: Mechanisms and Therapeutic Insights. Molecules. 2025;30(9):1972. doi: 10.3390/molecules30091972.
  14. Li X, Zou Y, Fu YY, et al. A-Lipoic Acid Alleviates Folic Acid-Induced Renal Damage Through Inhibition of Ferroptosis. Front Physiol. 2021;12:680544. doi: 10.3389/fphys.2021.680544.
  15. Cho HS, Kim JH, Jang HN, et al. Alpha-lipoic acid ameliorates the epithelial mesenchymal transition induced by unilateral ureteral obstruction in mice. Sci Rep. 2017;7:46065. doi: 10.1038/srep46065.
  16. Oktan MA, Heybeli C, Ural C, et al. Alpha-lipoic acid alleviates colistin nephrotoxicity in rats. Hum Exp Toxicol. 2021;40(5):761-771. doi: 10.1177/0960327120966043.
  17. Aprioku JS, Nwidu LL, Amadi CN. Evaluation of toxicological profile of ibuprofen in Wistar albino rats. Am J Biomed Sci. 2014;6(1):32-40.
  18. Gibson-Corley KN, Olivier AK, Meyerholz DK. Principles for valid histopathologic scoring in research. Vet Pathol. 2013;50(6):1007-1015. doi: 10.1177/0300985813485099.
  19. Tozak Yıldız H, Kalkan KT, Baydilli N, et al. Anti-Fibrotic and Regenerative Potential of Mesenchymal Stem Cell-Derived Exosomes in Cisplatin-Induced Kidney Injury. Journal of Uludağ University Medical Faculty. 2025;51(2):223-231. doi:10.32708/uutfd.1691390.
  20. Razzaq SA, Aboshnin ZA. Amelioration of ibuprofen induced hepato-renal injury: biochemical and histological study in rats. J Chem Health Risks. 2023;13(4):539-546.
  21. Elkomy A, Aboubakr M, Ashraf L. Ameliorative Effect of Thymus Oil on Paracetamol Induced Hepato-Renal Toxicity: A Biochemical, Antioxidant and Histopathological Studies. J Pharmacol Clin Res. 2017;4(3):555637. doi: 10.19080/JPCR.2017.04.555637.
  22. Drożdżal S, Lechowicz K, Szostak B, et al. Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature. Pharmacol Res Perspect. 2021;9(4):e00817. doi: 10.1002/prp2.817.
  23. Martinelli I, Tomassoni D, Roy P, Di Cesare Mannelli L, Amenta F, Tayebati SK. Antioxidant Properties of Alpha-Lipoic (Thioctic) Acid Treatment on Renal and Heart Parenchyma in a Rat Model of Hypertension. Antioxidants (Basel). 2021;10(7):1006. doi: 10.3390/antiox10071006.
  24. Dugbartey GJ, Alornyo KK, N'guessan BB, Atule S, Mensah SD, Adjei S. Supplementation of conventional anti-diabetic therapy with alpha-lipoic acid prevents early development and progression of diabetic nephropathy. Biomed Pharmacother. 2022;149:112818. doi: 10.1016/j.biopha.2022.112818.
  25. Park CH, Yoo TH. TGF-β Inhibitors for Therapeutic Management of Kidney Fibrosis. Pharmaceuticals (Basel). 2022;15(12):1485. doi: 10.3390/ph15121485.
  26. Han S, Ma S, Liu K, et al. SRPK1 is a significant factor in driving the progression of diabetic kidney fibrosis. Diabetol Metab Syndr. 2025;17(1):316. doi: 10.1186/s13098-025-01889-0.
  27. Skibska B, Kochan E, Stanczak A, Lipert A, Skibska A. Antioxidant and Anti-inflammatory Effects of α-Lipoic Acid on Lipopolysaccharide-induced Oxidative Stress in Rat Kidney. Arch Immunol Ther Exp (Warsz). 2023;71(1):16. doi: 10.1007/s00005-023-00682-z.
  28. Dong J, Wang Y, Yi S, Zhao T, Xu Y. α-Lipoic acid ameliorates renal fibrosis in diabetic rats through TGF-β1/Smads signaling pathway. Minerva Med. 2022;113(1):216-218. doi: 10.23736/S0026-4806.20.07235-3.
  29. Kamt SF, Liu J, Yan LJ. Renal-Protective Roles of Lipoic Acid in Kidney Disease. Nutrients. 2023;15(7):1732. doi: 10.3390/nu15071732.
  30. Cavdar Z, Oktan MA, Ural C, et al. Renoprotective Effects of Alpha Lipoic Acid on Iron Overload-Induced Kidney Injury in Rats by Suppressing NADPH Oxidase 4 and p38 MAPK Signaling. Biol Trace Elem Res. 2020;193(2):483-493. doi: 10.1007/s12011-019-01733-3.